NCT04880161View on ClinicalTrials.gov

A Study to Evaluate Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID)

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 26, 2021

Primary Completion Date

December 22, 2021

Study Completion Date

February 21, 2022

Conditions
Covid19
Interventions
BIOLOGICAL

Ampion

Inhaled Ampion

OTHER

Placebo

Inhaled Placebo

Trial Locations (1)

80112

Ampio Pharmaceuticals, Englewood

Sponsors
All Listed Sponsors
lead

Ampio Pharmaceuticals. Inc.

INDUSTRY

NCT04880161 - A Study to Evaluate Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID) | Biotech Hunter | Biotech Hunter